Abstract:CRISPR/Cas9 precision genome editing has revolutionized cancer treatment by introducing specific alterations to the cancer genome. But the therapeutic potential of CRISPR/Cas9 is limited by off-target effects, which can cause undesired changes to genomic regions and create major safety concerns. The primary emphasis lies in their implications within the realm of cancer photodynamic therapy (PDT), where precision is paramount. PDT is a promising cancer treatment method; nevertheless, its effectiveness is severely limited and readily leads to recurrence due to the therapeutic resistance of cancer stem cells (CSCs). With a focus on targeted genome editing into cancer cells during PDT and stem cell treatment (SCT), the review aims to further the ongoing search for safer and more accurate CRISPR/Cas9-mediated methods. At the core of this exploration are recent advancements and novel techniques that offer promise in mitigating the risks associated with off-target effects. With a focus on cancer PDT and SCT, this review critically assesses the landscape of off-target effects in CRISPR/Cas9 applications, offering a comprehensive knowledge of their nature and prevalence. A key component of the review is the assessment of cutting-edge delivery methods, such as technologies based on nanoparticles (NPs), to optimize the distribution of CRISPR components. Additionally, the study delves into the intricacies of guide RNA design, focusing on advancements that bolster specificity and minimize off-target effects, crucial elements in ensuring the precision required for effective cancer PDT and SCT. By synthesizing insights from various methodologies, including the exploration of innovative genome editing tools and leveraging robust validation methods and bioinformatics tools, the review aspires to chart a course towards more reliable and precise CRISPR-Cas9 applications in cancer PDT and SCT. For safe PDT and SCT integration in cancer therapy, CRISPR/Cas9 precision optimization is essential. Utilizing sophisticated molecular and computational techniques to address off-target effects is crucial to realizing the therapeutic promise of these technologies, which will ultimately lead to the development of individualized and successful cancer treatment strategies. Our long-term goals are to improve precision genome editing for more potent cancer therapy approaches by refining the way CRISPR/Cas9 is integrated with photodynamic and stem cell therapies.

Optimizing CRISPR/Cas9 precision: Mitigating off-target effects for safe integration with photodynamic and stem cell therapies in cancer treatment

Beyond the promise: evaluating and mitigating off-target effects in CRISPR gene editing for safer therapeutics

Harnessing the evolving CRISPR/Cas9 for precision oncology

Targeting Cancer with CRISPR/Cas9-Based Therapy

Mitigating off-target effects in CRISPR/Cas9-mediated in vivo gene editing

CRISPR/Cas9-Mediated Customizing Strategies for Adoptive T-Cell Therapy

Current updates of CRISPR/Cas9-mediated genome editing and targeting within tumor cells: an innovative strategy of cancer management

A review on CRISPR/Cas: a versatile tool for cancer screening, diagnosis, and clinic treatment

Genome Editing Approaches with CRISPR/Cas9 for Cancer Treatment: Critical Appraisal of Preclinical and Clinical Utility, Challenges, and Future Research

CRISPR-Cas and CRISPR-based screening system for precise gene editing and targeted cancer therapy

Recent Advances in Genome-Editing Technology with CRISPR/Cas9 Variants and Stimuli-Responsive Targeting Approaches within Tumor Cells: A Future Perspective of Cancer Management

Recent Advancements in Reducing the Off-Target Effect of CRISPR-Cas9 Genome Editing

Progress in the application of gene editing technology in cancer treatmentstaking CRISPR as an example

Precision Gene Editing Strategies with CRISPR-Cas9 for Advancing Cancer Immunotherapy and Alzheimer's Disease

CRISPR/Cas: Advances, Limitations, and Applications for Precision Cancer Research

Targeting Specificity of the CRISPR/Cas9 System.

Precision oncology revolution: CRISPR-Cas9 and PROTAC technologies unleashed

Molecular mechanisms, off‐target activities, and clinical potentials of genome editing systems

Approaches to Reduce CRISPR Off-Target Effects for Safer Genome Editing

CRISPR/Cas9: A powerful genome editing technique for the treatment of cancer cells with present challenges and future directions

Comprehensive review of CRISPR-based gene editing: mechanisms, challenges, and applications in cancer therapy